The cytokine IL-18 is another potential target in sJIA, as studies have shown that patients with sJIA have high levels of IL-18 and substantially increased levels may be associated with risk of MAS66–70. The gene discussed is IL18; the disease is systemic-onset juvenile idiopathic arthritis.